2002
DOI: 10.1016/s0960-894x(01)00709-0
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis and structure–activity relationships of oxime neurokinin antagonists: discovery of potent arylamides

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
6
0

Year Published

2002
2002
2016
2016

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 15 publications
(6 citation statements)
references
References 6 publications
0
6
0
Order By: Relevance
“…Among other species, optically active 3-aryl-4-pentenoic acid is an important substrate for the synthesis of numerous medicaments such as rolipram, an anti-inflammatory drug and one of the family of γ-aminobutyric acid (GABA) derivatives, as well as citrocard, lioresal, femoxetine, and paroxetine, other drugs belonging to the GABA family . Optically active 3-phenyl-4-pentenoic acid is the key intermediate in the synthesis of LG 121071, a modulator of androgen receptors and neurokinin NK1/NK2 antagonists . ( S )-3-Aryl-4-pentenoic acid derivatives have also been used for the synthesis of antiproliferation lactones (HL-60 cell inhibitors), , antimicrobial agents, and also the antitumor antibiotic methylenolactocin (Figure ).…”
Section: Introductionmentioning
confidence: 99%
“…Among other species, optically active 3-aryl-4-pentenoic acid is an important substrate for the synthesis of numerous medicaments such as rolipram, an anti-inflammatory drug and one of the family of γ-aminobutyric acid (GABA) derivatives, as well as citrocard, lioresal, femoxetine, and paroxetine, other drugs belonging to the GABA family . Optically active 3-phenyl-4-pentenoic acid is the key intermediate in the synthesis of LG 121071, a modulator of androgen receptors and neurokinin NK1/NK2 antagonists . ( S )-3-Aryl-4-pentenoic acid derivatives have also been used for the synthesis of antiproliferation lactones (HL-60 cell inhibitors), , antimicrobial agents, and also the antitumor antibiotic methylenolactocin (Figure ).…”
Section: Introductionmentioning
confidence: 99%
“…The apparently low efficacy of NK1R antagonists in the treatment of pain in humans has been attributed to inadequate clinical trials (84). Alternatively, several dual antagonists of NK1Rs and NK2Rs have been developed (67,77). With the exception of ZD-6021, which has been shown to dose dependently attenuate plasma extravasation in guinea pigs (6), little if any investigation of the therapeutic potential of dual antagonists has been done.…”
mentioning
confidence: 99%
“…The oxazoline moiety of the above products should be useful for further transformations 1. For example, hydrolysis of 34 with dilute aqueous acid effected concomitant desilylation (Scheme ) to give a 3‐aryl‐4‐pentenoic acid 39 , which is a known precursor for the synthesis of neurokinin receptor antagonists 15…”
Section: Methodsmentioning
confidence: 99%